AstraZeneca

Page 8 of 13

Public health officials warn about slow vaccine rollout as coronavirus variants multiply
Health

Public health officials warn about slow vaccine rollout as coronavirus variants multiply

By James Paton and Bloomberg
January 18, 2021
A photo of Jonas Salk injecting a boy with the polio vaccine he invented.
Health

The COVID-19 vaccination drive may be slow—but it’s already faster than any in history

By
January 17, 2021
Sick patients over 80 could be a COVID vaccine risk, Norwegian health officials warn
Health

Sick patients over 80 could be a COVID vaccine risk, Norwegian health officials warn

By Lars Erik Taraldsen, Naomi Kresge and Bloomberg
January 15, 2021
Drugmakers hit back at U.K. plan to delay the second dose of COVID vaccines
Health

Drugmakers hit back at U.K. plan to delay the second dose of COVID vaccines

By James Paton and Bloomberg
January 13, 2021
EU regulators approve Moderna’s COVID vaccine as pressure builds to speed up immunizations
Health

EU regulators approve Moderna’s COVID vaccine as pressure builds to speed up immunizations

By Naomi Kresge and Bloomberg
January 6, 2021
U.K. Prime Minister Boris Johnson holding a vial of AstraZeneca's Covid-19 vaccine.
Health

U.K. approves AstraZeneca COVID-19 vaccine

By
December 30, 2020
AstraZeneca-Oxford COVID vaccine could get U.K. approval as soon as this week
Health

AstraZeneca-Oxford COVID vaccine could get U.K. approval as soon as this week

By Viren Vaghela, Thomas Penny and Bloomberg
December 28, 2020
Why Wall Street is ‘signaling caution’ for your stock portfolio in 2021
Newsletters

Why Wall Street is ‘signaling caution’ for your stock portfolio in 2021

By
December 15, 2020
Photo of AstraZeneca CEO Pascal Soriot
Finance

Why shareholders had a severe adverse reaction to AstraZeneca’s Alexion deal

By
December 14, 2020
COVID vaccines are coming—but it might be too late for the housing market
Newsletters

COVID vaccines are coming—but it might be too late for the housing market

By
December 14, 2020
AstraZeneca acquires rare-disease specialist Alexion in $39 billion deal
Health

AstraZeneca acquires rare-disease specialist Alexion in $39 billion deal

By John Lauerman, James Paton and Bloomberg
December 13, 2020
Who gets first dibs on a COVID-19 vaccine? The U.K.’s historic rollout today reveals who gets precedence
Health

Who gets first dibs on a COVID-19 vaccine? The U.K.’s historic rollout today reveals who gets precedence

By
December 8, 2020
The global rally stalls out, but Goldman Sachs is doubling down on value stocks
Newsletters

The global rally stalls out, but Goldman Sachs is doubling down on value stocks

By
December 7, 2020
Airlines are facing ‘mission of the century’ in shipping COVID vaccines
Health

Airlines are facing ‘mission of the century’ in shipping COVID vaccines

By Christopher Jasper, William Wilkes and Bloomberg
December 1, 2020
AstraZeneca COVID-19 vaccine comes under scrutiny again, this time in India
International

AstraZeneca COVID-19 vaccine comes under scrutiny again, this time in India

By
November 30, 2020

Most Popular